| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-09-2782 |
| P698 | PubMed publication ID | 20559023 |
| P50 | author | Jean-François Tanti | Q57320836 |
| P2093 | author name string | Jean-François Tanti | |
| Frédéric Bost | |||
| Issam Ben Sahra | |||
| P433 | issue | 5 | |
| P921 | main subject | metformin | Q19484 |
| prostate cancer | Q181257 | ||
| apoptotic process | Q14599311 | ||
| autophagy | Q288322 | ||
| P304 | page(s) | 670-671 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Autophagy | Q1255295 |
| P1476 | title | The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells | |
| P478 | volume | 6 |
| Q39545042 | 2-Aminophenoxazine-3-one and 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one cause cellular apoptosis by reducing higher intracellular pH in cancer cells |
| Q26830077 | Adipocytes: impact on tumor growth and potential sites for therapeutic intervention |
| Q36926125 | Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment |
| Q36906195 | Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer |
| Q26778008 | Cell Death Conversion under Hypoxic Condition in Tumor Development and Therapy |
| Q26748730 | Cellular Energetics as a Target for Tumor Cell Elimination |
| Q36028914 | Combined 2-deoxy glucose and metformin improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cells |
| Q37471852 | Contextual inhibition of fatty acid synthesis by metformin involves glucose-derived acetyl-CoA and cholesterol in pancreatic tumor cells |
| Q28544861 | Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells |
| Q26771300 | Energy disruptors: rising stars in anticancer therapy? |
| Q37437550 | Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer |
| Q39490136 | Glycolysis inhibition by 2-deoxy-D-glucose reverts the metastatic phenotype in vitro and in vivo. |
| Q22252348 | How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models |
| Q48544710 | Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin. |
| Q26771751 | Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics |
| Q34412152 | Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. |
| Q48831355 | Metformin Promotes AMP-activated Protein Kinase-independent Suppression of ΔNp63α Protein Expression and Inhibits Cancer Cell Viability |
| Q37837675 | Metformin and cancer: new applications for an old drug |
| Q36082226 | Metformin as an anticancer drug: A Commentary on the metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides |
| Q33610569 | Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones). |
| Q35600122 | Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response |
| Q47205983 | Metformin sensitizes lung cancer cells to treatment by the tyrosine kinase inhibitor erlotinib |
| Q37354564 | Metformin targets c-MYC oncogene to prevent prostate cancer. |
| Q26795735 | Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic Targets |
| Q40949691 | NHX-5, an Endosomal Na+/H+ Exchanger, Is Associated with Metformin Action. |
| Q34787732 | Principles and current strategies for targeting autophagy for cancer treatment |
| Q37091483 | Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions |
| Q41914031 | Synergistic Anticancer Action of Lysosomal Membrane Permeabilization and Glycolysis Inhibition |
| Q36439839 | TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression |
| Q37702768 | Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin |
| Q34411761 | Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model |
| Q35760966 | The combination of tephrosin with 2-deoxy-D-glucose enhances the cytotoxicity via accelerating ATP depletion and blunting autophagy in human cancer cells |
| Q42831411 | The synergism of MCL1 and glycolysis on pediatric acute lymphoblastic leukemia cell survival and prednisolone resistance |
| Q36887716 | Therapeutic strategies targeting cancer stem cells |
| Q26800890 | Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents |
| Q26750845 | Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs |
Search more.